Dan Leonard was appointed President and Chief Executive Officer of The Association for Accessible Medicines (AAM) today by the association’s Board of Directors. Leonard will begin his tenure in September, succeeding Chester “Chip” Davis, Jr. who left AAM in February 2020.
Leonard previously served as President and Chief Executive Officer of the National Pharmaceutical Council (NPC). In addition to his extensive industry experience, Mr. Leonard worked as a communications and media professional and has over 20 years of experience in strategic communications, legislative management, politics and broadcast journalism.
“Dan’s decades of leadership experience across the pharmaceutical ecosystem and his unparalleled background in policy and communications makes him the perfect person to lead our industry’s efforts to advocate for policies to increase patient access to generic and biosimilar medicines through greater competition,” said Alok Sonig, CEO, US Generics and Head, Global R&D and Biosimilars of Lupin Ltd., and Chairman of the AAM Board of Directors. Read more here.
(Source: Association for Accessible Medicines, August 25, 2020)